Patents Assigned to NOVILUX, LLC
  • Patent number: 12411139
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Grant
    Filed: September 6, 2023
    Date of Patent: September 9, 2025
    Assignee: Novilux, LLC
    Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H. B. Wu
  • Patent number: 11561177
    Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: January 24, 2023
    Assignee: NOVILUX, LLC
    Inventor: Richard Livingston